Method for treating blood clotting factor inhibitors
US4287180A · kind A · utility
20Cited by
4References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 28, 1980 |
| Grant date | Sep 1, 1981 |
| Priority date | — |
| Expiry date | Jan 28, 2000 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions including, in units/ml, factor VIII correctional activity, about from 2-35; prothrombin, about from 1-10; thrombin, less than about 0.003; factor VII, about from 37-190; factor VIIa, about from 8-80; total factor IX, about from 15-112; factor IX precursor, 0 to about 30; factor X, about from 1-30; and factor Xa, about from 1-10 are used in therapeutically effective amounts to treat blood clotting factor inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.